Related Experiment Video
Updated: Jun 21, 2026

11:02
In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model
Published on: October 3, 2011
Elevated mPer1 gene expression in tumor stroma imaged through bioluminescence.
Michael E Geusz1, Kenneth T Blakely, Daniel J Hiler
1Department of Biological Sciences, Bowling Green State University, Bowling Green, OH 43403-0208, USA. mgeusz@bgsu.edu
International Journal of Cancer
|July 29, 2009
Summary
The study reveals that the mPer1 clock gene is active in the tumor stroma, not cancer cells, suggesting localized circadian clock gene roles in cancer progression. This finding may lead to new stromal cell-targeted therapies.
Area of Science:
- Oncology
- Chronobiology
- Molecular Biology
Background:
- Tumor stroma significantly influences cancer growth and metastasis.
- Circadian timing systems, regulated by clock genes like mPer1, impact physiological rhythms and can affect tumor progression.
- Interactions between cancer and stromal cells are crucial but poorly understood.
Purpose of the Study:
- To investigate the role of the mPer1 clock gene in tumor-stromal interactions.
- To visualize mPer1 expression patterns within tumors using a novel bioluminescent imaging approach.
- To determine if tumor growth affects systemic circadian rhythms or mPer1 expression outside the tumor.
Main Methods:
- Utilized non-bioluminescent Lewis lung carcinoma (LLC) cells to establish tumors in transgenic mice expressing luciferase under the mPer1 promoter.
- Employed bioluminescence imaging to detect mPer1 activity in live mice and excised tumors.
- Monitored mouse wheel-running activity to assess systemic circadian rhythmicity.
Main Results:
- Bioluminescence, indicating mPer1 activity, was significantly elevated within the tumor stroma but not in cancer cells.
- mPer1 activity was detectable through the skin and in direct tumor imaging.
- No disruption of systemic circadian rhythms or mPer1 expression outside the tumor was observed during three weeks of tumor growth.
Conclusions:
- mPer1 activity in the tumor microenvironment plays a localized role in cancer-stromal cell interactions.
- Circadian clock genes in stromal cells may represent a potential therapeutic target for cancer treatment.
- Further research could explore clinical applications of targeting stromal circadian pathways.

